Revisão sistemática e metanálise dos desfechos CV e renais dos iSGLT2 - Euler Manenti - #Podcast 158
Feb 26, 2021
Autor: Euler Manenti
Ref: SGLT2 inhibitors for primary and secondary prevention of
cardiovascular and renal outcomes in type 2 diabetes: a systematic
review and meta-analysis of cardiovascular outcome trials. Lancet.
2018 Nov 9.
Feb 24, 2021
Autor: Carlos Eduardo Barra Couri
Ref: Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
N Engl J Med. 2018 Nov 10.
Feb 22, 2021
Autor: Cristiano Barcellos
Ref: Increased androgen levels in rats impair glucose-stimulated
insulin secretion through disruption of pancreatic beta cell
mitochondrial function. J Steroid Biochem Mol Biol. 2015
Nov;154:254-66.
Feb 19, 2021
Autor: Mônica Gabbay
Ref: Effect of metformin on glycaemic control in patients with
type 1 diabetes: A meta-analysis of randomized controlled trials.
Diabetes Metab Res Rev. 2018 May;34(4):e2983.
Feb 18, 2021
Autor: André Vianna
Ref: International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 2017 Dec;40(12):1631-1640.